Stock listing
SPTX Stock Price, News, Filings & Events — Seaport Therapeutics, Inc.
Selected listing: SPTX · BOATS · USD · US
This page tracks Seaport Therapeutics, Inc.'s SPTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SPTX:BOATS. SPTX:BOATS is the stock-level entry point for investors researching Seaport Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Seaport Therapeutics, Inc. (SPTX) is a public company based in the United States, focusing on innovative therapeutic solutions. With a market capitalization of approximately $1.12 billion, Seaport Therapeutics is positioned within the healthcare sector, aiming to advance treatment options. The company is committed to developing its portfolio to address unmet medical needs.

- Ticker
- SPTX:BOATS
- Asset type
- Stock
- Market cap
- $1.25B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Seaport Therapeutics, Inc. SPTX:BOATS stock context
This page tracks Seaport Therapeutics, Inc.'s SPTX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SPTX:BOATS. SPTX:BOATS is the stock-level entry point for investors researching Seaport Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Seaport Therapeutics, Inc. (SPTX) is a public company based in the United States, focusing on innovative therapeutic solutions. With a market capitalization of approximately $1.12 billion, Seaport Therapeutics is positioned within the healthcare sector, aiming to advance treatment options. The company is committed to developing its portfolio to address unmet medical needs.
Latest news from Seaport Therapeutics, Inc.
Seaport Therapeutics to Participate in September Investor Conferences
September 14, 2026
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
August 3, 2026
PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAg...
June 9, 2026
Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers
June 8, 2026
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
June 8, 2026
Research Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for SPTX:BOATS.
Seaport Therapeutics, Inc. company profile
View the public company page for Seaport Therapeutics, Inc. on 6ix.
Seaport Therapeutics, Inc. news
Read company news and market updates connected to Seaport Therapeutics, Inc..
Seaport Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Seaport Therapeutics, Inc..